CONTACT: GEORGE MCCRORY
100 Old Public Library
Iowa City IA 52242
(319) 384-0012; fax (319) 384-0024
Release: May 10, 2001
PHOTO OPPORTUNITY: Congressman Jim Leach and University of Iowa President
Mary Sue Coleman view the robotics and laboratory areas at the Biocatalysis
Division of Albany Molecular Research, Inc.
WHAT: An open house at Albany Molecular Research's (NASDAQ:AMRI) new
10,000 square-foot facility.
WHO: Invited guests include Iowa Congressman Jim Leach; University
of Iowa President Mary Sue Coleman; and Albany Molecular Research, Inc. Vice
President of Operations Jim Grates.
WHEN: 3 to 5 p.m., Monday, May 14. Ceremony and open house begins
at 3:30 p.m. Lab tours for the media and dignitaries will run from 2:45 p.m.
to 3:15 p.m. Photo and video opportunities will be available during this time
as Congressman Leach and President Coleman view the division's robotics and
laboratory areas. Guided tours for other invited guests will be available
from 4 to 5 p.m.
WHERE: Albany Molecular Research Inc. Biocatalysis Division, University
of Iowa Oakdale Research Park, 2660 Crosspark Road, Coralville.
WHY: The AMRI expansion project represents an investment of $3 million
in facilities and equipment and is expected to support the addition of at
least 25 new employees. The expansion was made possible through a partnership
between AMRI, the City of Coralville, the University of Iowa Oakdale Research
Park, and the Iowa Department of Economic Development.
ß AMRI is a leading chemistry research, drug discovery and development
company focusing on applications for the life sciences industries. The company
performs comprehensive chemistry research for many of the leading pharmaceutical
and biotechnology companies and for its own internal research and development.
Last year, AMRI placed second among Forbes magazine's "200 Best Small
Companies in America" and fourth on Business Week's list of 100 top growth
companies. AMRI acquired its Biocatalysis Division, formerly known as EnzyMed
Inc. in 1999.